Daniel Menold, Vice President, Finance at CymaBay Therapeutics, Inc. (CBAY), sold 20,000 shares at $23.58 ($472K) on 2024-01-16, disclosed to the SEC on 2024-01-16.
Scheduled sale ($472k) by Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.58 | 10,000 | $236K | 50.0% |
| 2 | $23.58 | 10,000 | $236K | 50.0% |
| Total | $23.58 avg | 20,000 | $472K | 100% |
| Filing → |
| CBAY | SELL | 2018-08-31 | $65K | — | Filing → |